These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 1096987)

  • 1. Use of transfer factor in patients with depressed cellular immunity and chronic infection.
    Rocklin RE
    Birth Defects Orig Artic Ser; 1975; 11(1):431-5. PubMed ID: 1096987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of cell-mediated immune responses with transfer factor.
    Kirkpatrick CH
    Birth Defects Orig Artic Ser; 1975; 11(1):441-4. PubMed ID: 1096989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of transfer factor on lymphocyte function in anergic patients.
    Kirkpatrick CH; Rich RR; Smith TK
    J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfer factor as an approach to the treatment of immune deficiency disease.
    Schulkind ML; Ayoub EM
    Birth Defects Orig Artic Ser; 1975; 11(1):436-40. PubMed ID: 1096988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfer factor II: results of therapy.
    Spitler LE; Levin AS; Fudenberg HH
    Birth Defects Orig Artic Ser; 1975; 11(1):449-56. PubMed ID: 1096990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconstitution of defective cellular immunity with foetal thymus and dialysable transfer factor. Long-term studies in a patient with chronic mucocutaneous candidiasis.
    Kirkpatrick CH; Ottenson EA; Smith TK; Wells SA; Burdick JF
    Clin Exp Immunol; 1976 Mar; 23(3):414-28. PubMed ID: 947642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic features of chronic granulomatous mucocutaneous candidiasis before and after treatment with transfer factor.
    Horsmanheimo M; Krohn K; Virolainen M; Blomqvist K
    Arch Dermatol; 1979 Feb; 115(2):180-4. PubMed ID: 426525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfer factor therapy in immunodeficiency.
    Griscelli C
    Birth Defects Orig Artic Ser; 1975; 11(1):462-4. PubMed ID: 1148388
    [No Abstract]   [Full Text] [Related]  

  • 9. Guidelines for immunotherapy of antigen-specific defects with transfer factor.
    Wilson GB; Fudenberg HH; Keller RH
    J Clin Lab Immunol; 1984 Feb; 13(2):51-8. PubMed ID: 6202873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of immunologic deficiency conditions by means of transfer factor].
    Kobielowa Z
    Pediatr Pol; 1975 Nov; 50(11):1393-7. PubMed ID: 1103073
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic mucocutaneous candidiasis accompanied by enhanced antibody production.
    Takeya K; Nomoto K; Matsumoto T; Miyake T; Himeno K
    Clin Exp Immunol; 1976 Sep; 25(3):497-500. PubMed ID: 786522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parameters of T cell mediated immunity to commensal micro-organisms in patients with chronic purulent rhinosinusitis: a comparison between delayed type hypersensitivity skin test, lymphocyte transformation test and macrophage migration inhibition factor assay.
    van de Plassche-Boers EM; Drexhage HA; Kokjé-Kleingeld M; Leezenberg HA
    Clin Exp Immunol; 1986 Dec; 66(3):516-24. PubMed ID: 3552334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfer factor therapy in immuno-deficiencies.
    Griscelli C; Revillard JP; Betuel H; Herzog C; Touraine JL
    Biomedicine; 1973 May; 18(3):220-7. PubMed ID: 4742861
    [No Abstract]   [Full Text] [Related]  

  • 14. Mucocutaneous candidiasis, anergy and a plasma inhibitor of cellular immunity: reversal after amphotericin B therapy.
    Paterson PY; Semo R; Blumenschein G; Swelstad J
    Clin Exp Immunol; 1971 Nov; 9(5):595-602. PubMed ID: 4947556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological features in a case of chronic granulomatous candidiasis and its treatment with transfer factor.
    Valdimarsson H; Wood CB; Hobbs JR; Holt PJ
    Clin Exp Immunol; 1972 Jun; 11(2):151-63. PubMed ID: 4557179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunodeficiencies in chronic muco-cutaneous candidosis.
    Lehner T; Wilton JM; Ivanyi L
    Immunology; 1972 May; 22(5):775-87. PubMed ID: 4336639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Wiskott-Aldrich syndrome. Results of transfer factor therapy.
    Spitler LE; Levin AS; Stites DP; Fudenberg HH; Pirofsky B; August CS; Stiehm ER; Hitzig WH; Gatti RA
    J Clin Invest; 1972 Dec; 51(12):3216-24. PubMed ID: 4640955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfer factor therapy: evidence for nonspecificity.
    Ballow M; Dupont B; Hansen JA; Good RA
    Birth Defects Orig Artic Ser; 1975; 11(1):457-61. PubMed ID: 125119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The macrophage aggregation assay for cell-mediated immunity in man. Studies of patients with Hodgkin's disease and sarcoidosis.
    Gotoff SP; Lolekha S; Lopata M; Kopp J; Kopp RL; Malecki TJ
    J Lab Clin Med; 1973 Oct; 82(4):682-91. PubMed ID: 4585463
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic mucocutaneous candidiasis.
    J Cutan Pathol; 1974; 1(5):211-29. PubMed ID: 4470726
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.